15 versus 45 minute liver clamp in cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial compares two different time limits for temporarily clamping the blood supply to the liver during surgery to remove liver cancer. The goal is to see if a shorter clamp time (15 minutes) works just as well as the standard longer time (45 minutes) while possibly reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a primary or secondary liver cancer diagnosis.
- You are over 18 years old.
- You are scheduled for surgery to remove part of your liver.
- You are in fairly good health (WHO score 2 or less).
- You do not have cirrhosis or significant liver damage.
- This is your first liver surgery for cancer (no prior liver surgery, ablation, or chemoembolization).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a technique called the Pringle maneuver (temporarily stopping blood flow to the liver during surgery) affects gallbladder health after liver surgery. It is for people having a liver tumor removed while keeping their gallbladder.
This trial tests a new way to control blood flow during laparoscopic liver surgery. It compares two methods to see which is safer and more effective for patients with certain liver conditions.
This study compares two ways of doing a staged liver surgery (ALPPS) to help regrow enough liver for people with certain liver cancers. It looks at outcomes and how well the remaining liver grows after surgery, using different surgical approaches.
This trial looks at how major liver surgery with controlled blood flow (vascular clamping) affects patients. It may help doctors improve outcomes for people who need this type of operation.
This trial tests a two-step surgery for colorectal cancer that has spread only to the liver. The goal is to remove all visible liver tumors by first dividing the liver and blocking blood flow to the diseased side, which helps the healthy side grow larger so it can be safely removed in a second surgery.
This trial compares two ways to treat colorectal cancer that has spread to the liver: removing liver tumors with surgery versus destroying them in place with local ablation. It may help doctors learn which approach works best for people whose disease can be fully treated and who have enough healthy liver left.
Hear when a new Liver Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.